Análisis Argos
AGL
AGLSin veredicto2 señales de riesgo
Agilon Health, Inc. · Healthcare
US$ 122.61
precio al 2026-07-14
Valor justo Argos*
Sin estimar
vs. su valor justo
Sin estimar
Score Argos
11/100
Sin veredicto
LA RESPUESTA
No tenemos un veredicto de valuación confiable acá: su flujo de caja no permite una estimación sólida. Mirá su calidad y su salud para formarte una idea — preferimos eso a inventarte un número.
Recompensas
Tiene más caja que deuda: balance fuerte.
Riesgos
!Venta significativa de insiders en el último trimestre.
!Balance frágil: la deuda pesa sobre el negocio.
!Altman Z'' en zona roja (-7.08)
!Piotroski F-Score débil (3/9)
VALOR0/6FUTURO5/6PASADO0/6SALUD1/6DIVIDENDO1/6
El Iris de calidad
VALOR0/6FUTURO5/6PASADO0/6SALUD1/6DIVIDENDO1/6
ValorCotiza por encima de su valor justo
FuturoIngresos creciendo con fuerza
PasadoHistorial débil
SaludBalance frágil
DividendoEl dividendo aún duerme
Score Argos11de 100Sin veredicto
Ingresos2%
US$ 5.9 B
Margen operativo48%
-7.1%
Flujo de caja libre71%
US$ -0.1 B
Deuda neta
US$ -0.1 B
Lo esencial, sin ruido
Cap. de mercadoUS$ 2.0B
P/E
EV/EBITDA
FCF yield-5.8%
ROIC
Margen operativo-7.1%
Crecim. ingresos-2.1%/año
Piotroski F3/9
Novedades

Noticias recientes

businesswire.com · 10 jul
agilon health Reports ACO REACH Model Results for 2024 Performance Year
WESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that its Accountable Care Organizations (ACOs) achieved $229 million in gross savings (13.6% gross savings rate), including $54 million savings in the Medicare Trust Fund, during the 2024 performance year of the ACO Realizing Equity, Access and Community Health (ACO REACH) model. agilon's eight REACH ACOs operate under full risk, a.
businesswire.com · 7 jul
agilon health Sets Date to Report Second Quarter 2026 Financial Results
WESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced that it will release financial results for the second quarter 2026 after market close on Wednesday, August 5, 2026 and host a conference call at 4:30 p.m. ET to discuss the results. The conference call can be accessed by dialing (833) 439-1904 for U.S. participants and +1 (585) 542-9983 for international participants and refe.
zacks.com · 26 jun
Agilon Health (AGL) Is Up 0.79% in One Week: What You Should Know
Does Agilon Health (AGL) have what it takes to be a top stock pick for momentum investors? Let's find out.
zacks.com · 26 jun
Why Fast-paced Mover Agilon (AGL) Is a Great Choice for Value Investors
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Agilon (AGL) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
seekingalpha.com · 24 jun
agilon health: Q1 Inflection And A New CEO Set Up A Multi-Year Rerating
agilon health is rated Buy with a $177 price target, reflecting a robust Q1 beat and a positive inflection in financials. Q1 2026 delivered $1.42B revenue (+$40M vs. consensus), $54M adjusted EBITDA (+162% YoY), and raised full-year guidance across all key metrics. Margin expansion is driven by a new data pipeline, scaled clinical programs, disciplined payer contracting, and AI-driven risk scoring now fully operational.
zacks.com · 23 jun
Is the Options Market Predicting a Spike in agilon health Stock?
Investors need to pay close attention to AGL stock based on the movements in the options market lately.
businesswire.com · 9 jun
agilon health to Participate in Upcoming Conferences
WESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced that members of its management team will participate in investor meetings and industry discussions at the following conferences: Truist Securities Healthcare Disruptors & Digital Health Conference on Tuesday, June 23, 2026 in New York. Management will participate in an ACO Model panel discussion at 1:50pm ET and conduct o.
benzinga.com · 3 jun
These ETFs Owned Russell 2000's Biggest Winners Before They Soared 400%+ In 2026
Investors searching for the biggest stock winners of 2026 may be surprised to learn they already own some of them through small-cap ETFs.

* Valor justo Argos: estimación educativa del valor intrínseco según el propio flujo de caja de la empresa y su capacidad de crecimiento — no un precio objetivo ni una recomendación. Esto es información y educación, no asesoría de inversión. Rendimiento pasado no garantiza resultados futuros.